Ocular pathology of GM2 gangliosidosis--Type 2 (Sandhoff's disease).
نویسنده
چکیده
The introduction in recent years of more refined techniques for the isolation and characterization of biological lipids has led to the detection of a number of disorders which share with Tay-Sachs disease a disturbance of ganglioside metabolism. Gangliosides are sphingosine-containing glycolipids distinguished by the inclusion of neuraminic acid, and the various gangliosidoses are attributable to defects in the enzyme systems required for their degradation. Of the three disorders involving accumulation of the so-called GM2 ganglioside, Tay-Sachs disease (infantile amaurotic idiocy) is much the most common. Recent studies, however, have shown that GM2 ganglioside breakdown is dependent on hexosaminidase, a lysosomal enzyme which has two components referred to as A and B (Robinson and Stirling, I968), and that, whereas in Tay-Sachs disease the A component alone is deficient (Okada and O'Brien, I969), the entire enzyme is absent (Sandhoff, I969) in a related disorder first described by Sandhoff, Andreae, and Jatzkewitz (I968). This results in the accumulation, not only of GM2 ganglioside as in Tay-Sachs disease, but also of its neuraminic acid-free derivative (O'Brien, Okada, Ho, Fillerup, Veath, andAdams, I97I). The viscera in Sandhoff's disease accumulate a ceramide-based glycolipid, globoside, which is similarly dependent on hexosaminidase for its breakdown (O'Brien and others, I971). The clinical features and pathology of Sandhoff's and Tay-Sachs disease are virtually indistinguishable (Pilz, Sandhoff, andJatzkewitz, I966; O'Brien and others, I97I; Bain, Tateson, Anderson, and Cumings, 1972), and it is possible that a proportion of alleged Tay-Sachs cases, particularly in non-Jews, may in reality be examples of Sandhoff's disease. Reliable differentiation in life can be made only on the basis of serum and tissue hexosaminidase assay (Okada and O'Brien, I969; Okada, Veath, Leroy, and O'Brien, 197I; Bain and others, 1972). A full account of the clinical, pathological, and biochemical feature, excluding the ocular pathology, of Sandhoff's disease occurring in a Scottish family is given by Bain and others (1972). The present report concerns the ocular findings in one of their cases.
منابع مشابه
Microcephaly in infantile Sandhoff's disease.
Maulik K, et al. BMJ Case Rep 2017. doi:10.1136/bcr-2017-220912 Description We evaluated a boy aged 16 months with developmental arrest at the age of 6 months followed by neuroregression and recurrent generalised seizures. Perinatal and family history was not contributory. He was first born to non-consanguineous parents by term, uncomplicated vaginal delivery and weighed 2.8 kg at birth. On exa...
متن کاملTwo‐Year Follow‐Up Magnetic Resonance Imaging and Spectroscopy Findings and Cerebrospinal Fluid Analysis of a Dog with Sandhoff's Disease
A 13-month-old female Toy Poodle was presented for progressive ataxia and intention tremors of head movement. The diagnosis of Sandhoff's disease (GM2 gangliosidosis) was confirmed by deficient β-N-acetylhexosaminidase A and B activity in circulating leukocytes and identification of the homozygous mutation (HEXB: c.283delG). White matter in the cerebrum and cerebellum was hyperintense on T2-wei...
متن کاملPathology of GM2 gangliosidosis in Jacob sheep.
The G(M2) gangliosidoses are a group of lysosomal storage diseases caused by defects in the genes coding for the enzyme hexosaminidase or the G(M2) activator protein. Four Jacob sheep from the same farm were examined over a 3-year period for a progressive neurologic disease. Two lambs were 6-month-old intact males and 2 were 8-month-old females. Clinical findings included ataxia in all 4 limbs,...
متن کاملCanine GM2‐Gangliosidosis Sandhoff Disease Associated with a 3‐Base Pair Deletion in the HEXB Gene
BACKGROUND GM2-gangliosidosis is a fatal neurodegenerative lysosomal storage disease (LSD) caused by deficiency of either β-hexosaminidase A (Hex-A) and β-hexosaminidase B (Hex-B) together, or the GM2 activator protein. Clinical signs can be variable and are not pathognomonic for the specific, causal deficiency. OBJECTIVES To characterize the phenotype and genotype of GM2-gangliosidosis disea...
متن کاملAB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
Human kidney extracts heated to 60 degrees and devoid of hexosaminidase activity (2-acetamido-2-deoxy-beta-D-glucoside acetamidodeoxyglucohydrolase EC 3.2.1.30) stimulate more than 20-fold the hexosaminidase A-catalyzed degradation of ganglioside GM2 and of glycolipid GA2, the neuronal storage compounds of GM2 gangliosidosis. The stimulating factor of this extract, which is labile at temperatur...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The British journal of ophthalmology
دوره 57 7 شماره
صفحات -
تاریخ انتشار 1973